Trial · NCT00877487
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) With Adult Prompts Total Score at up to 6 Weeks | SPD489 | 1.6 | Standard Error 1.39 | Units on a scale | |
| Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS) With Adult Prompts Total Score at up to 6 Weeks | Placebo | 16.8 | Standard Error 1.35 | Units on a scale | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Normal, not at all ill | 32.1 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Normal, not at all ill | 5.0 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Borderline mentally ill | 35.7 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Borderline mentally ill | 11.7 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Mildly ill | 17.9 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Mildly ill | 11.7 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Moderately ill | 7.1 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Moderately ill | 33.3 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Markedly ill | 7.1 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Markedly ill | 35.0 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Severely ill | 0 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Severely ill | 3.3 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | SPD489 | Among the most extremely ill | 0 | Percent of Participants | |
| Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at up to 6 Weeks | Placebo | Among the most extremely ill | 0 | Percent of Participants | |
| Percent of Treatment Failures at up to 6 Weeks | SPD489 | 8.9 | Percent of participants | ||
| Percent of Treatment Failures at up to 6 Weeks | Placebo | 75.0 | Percent of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00877487/results